Romo-Pardo B, Liendo-Vallejos S, Vargas-López G, Rizzoli-Córdoba A, Buenrostro-Márquez G

Language: Spanish
References: 23
Page: 450-462
PDF size: 245.78 Kb.

ABSTRACT

Background. The American Academy of Pediatrics recommends the application of neurodevelopmental screening tests for early intervention of neurodevelopmental disorders. In order to refer these tests appropriately, it is important to have well-founded information in regard to these tools.
Methods. A systematic literature search targeted on validation studies of neurodevelopmental screening tests in children ‹ 5 years of age in the U.S. and Latin America from 1980 to 2012 was conducted.
Results. We found 19 validation studies of 13 screening tests. Battelle Developmental Screening Inventory (2nd edition) reported the best sensitivity and specificity (0.93/0.88) and PRUNAPE with predictive positive and negative values (0.94/0.97).
Conclusions. From 1980-2012 we found 13 neurodevelopmental screening tests in the U.S. and Latin America for children ‹ 5 years of age. The best criterion and predictive validity was for Battelle Developmental Inventory Screening and PRUNAPE, respectively. No validation studies were found in Mexico; therefore, we consider it important to have a validated tool in our country.

REFERENCES

1. Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006;118:405-420.

2. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Ritcher L, Strupp B, et al. Developmental potential in the first 5 years for children in developing countries. Lancet 2007;369:60-70.

3. Hamilton S. Screening for developmental delay: reliable, easyto- use tools. J Fam Pract 2006;55:415-422.

4. Rydz D, Srour M, Oskoui M, Marget N, Shiller M, Birnbaum R, et al. Screening for developmental delay in the setting of a community pediatric clinic: a prospective assessment of parent- report questionnaires. Pediatrics 2006;118:e1178-e1186.

5. Mackrides PS, Ryherd SJ. Screening for developmental delay. Am Fam Physician 2011;84:544-5499.

6. Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol 2005;20:4-21.

7. Glen P Aylward, T. S. Measurement and psychometric considerations. En: Wolraich ML, Drotar DD, Dworkin PH, Perrin EC, eds. Developmental-Behavioral Pediatrics: Evidence and Practice. Philladelphia: Mosby Elsevier; 2008. pp. 123-201.

8. Squires J, Bricker D, Potter L. Revision of a parent-completed developmental screening tool: Ages and Stages Questionnaires. J Pediatr Psychol 1997;22:313-328.

9. Squires J, Twombly E, Bricker D, Potter L. ASQ-3™ User’s Guide. Baltimore, MD: Paul H. Brookes Publishing Co., Inc; 2009.

10. Schonhaut BL, Salinas AP, Armijo RI, Schönstedt GM, Álvarez LJ, Manríquez OM. Validación de un cuestionario autoadministrado para la evaluación del desarrollo psicomotor. Rev Chil Pediatr 2009;80:513-519.

11. Limbos MM, Joyce DP. Comparison of the ASQ and PEDS in screening for developmental delay in children presenting for primary care. J Dev Behav Pediatr 2011;32:499-511.

12. Newborg J. Development and standardization. En: Newborg J, ed. Battelle Developmental Inventory. Itaska, IL: Riverside Publishing; 2004. pp. 95-148.

13. Aylward GP. The Bayley Infant Neurodevelopmental Screener (BINS): different test and different purpose. En: Weiss LG, Oakland T, Aylward G, eds. Bayley III Clinical Use and Interpretation. USA: Academic Press; 2010. pp. 201-233.

14. Glascoe FP. The Brigance Infant and Toddler Screen: standardization and validation. J Dev Behav Pediatr 2002;23:145-150.

15. Capute AJ, Shapiro BK, Watchel RC, Gunther VA, Palmer FB. The Clinical Linguistic and Auditory Milestone Scale (CLAMS). Identification of cognitive defects in motor-delayed children. Am J Dis Child 1986;140:694-698.

16. Doig KB, Macias MM, Saylor CF, Craver JR, Ingram PE. The Child Development Inventory: a developmental outcome measure for follow-up of the high-risk infant. J Pediatr 1999;135:358-362.

17. Glascoe FP, Byrne KE, Ashford LG, Johnson KL, Chang B, Strickland B. Accuracy of the Denver-II in developmental screening. Pediatrics 1992;89:1221-1225.

18. Schapira IT. Comentarios y aportes sobre desarrollo e inteligencia sensorio-motriz en lactantes. Análisis de herramientas de evaluación de uso frecuente. Actualización bibliográfica. Rev Hosp Mat Infant Ramón Sardá 2007;26:21-27.

19. Bedregal P. Instrumentos de medición del desarrollo en Chile. Rev Chil Pediatr 2008;79(suppl 1):32-36.

20. Vericat A, Orden AB. Herramientas de screening del desarrollo psicomotor en América. Rev Chil Pediatr 2010;81:391-401.

21. Guadarrama-Celaya F, Otero-Ojeda GA, Pliego-Rivero B, Porcayo-Mercado MR, Garcell JR, Pérez-Ábalo MC. Screening of neurodevelopmental delays in four communities of Mexico and Cuba. Public Health Nurs 2012;29:105-115.

22. Pascucci MC, Lejarraga H, Kelmansky D, Álvarez M, Boullón M, Breiter P, et al. Validación de la prueba nacional de pesquisa de trastornos de desarrollo psicomotor en niños menores de 6 años. Arch Argen Pediatr 2002;100:374-384.

23. Pascucci MC, Lejarraga H, Kelmansky D, Álvarez M, Boullón M, Breiter P, et al. Validación de la prueba nacional de pesquisa de trastornos de desarrollo psicomotor en niños menores de 6 años. Arch Pediatr Urug 2004;75:79-90.